Insights

Expanding Global Footprint Cryoport Systems is actively expanding its facilities, notably in France with the recent addition of the Pont-du-Château site and the launch of new cryopreservation services in Houston. This growth indicates open opportunities to engage with their expanding operational network and offer complementary solutions for their increased logistics and storage needs.

Innovative Technology Development Cryoport has recently launched advanced cryogenic shipping systems, including the Cryoport Express Cryogenic HV3. This focus on cutting-edge temperature-controlled solutions presents opportunities to introduce innovative packaging, monitoring, and support services tailored to their high-tech logistics infrastructure.

Strategic Partnerships and Acquisitions The company's recent partnership with TMRW Life Sciences and acquisition of Tec4med Lifescience reflect their strategic focus on expanding capabilities in specimen management and biostorage. These collaborations open avenues to collaborate on or supplement their integrated solutions with additional technology and expertise.

Industry Focus on Cell and Gene Therapies Cryoport specializes in supply chain solutions specifically for regenerative medicine, cell and gene therapies, and personalized treatments. Businesses offering specialized packaging, regulatory compliance, or biostorage services targeting these niche markets can position themselves as valuable partners to support Cryoport’s core business verticals.

Financial Growth Opportunities With significant funding of $25 million and emerging revenue streams, Cryoport appears poised for rapid growth. Engaging with them through scalable logistics, innovative cold chain solutions, or regulatory support services could align with their expansion strategy and help capture a portion of their increasing market share.

Similar companies to Cryoport Systems (formerly Cell&Co)

Cryoport Systems (formerly Cell&Co) Tech Stack

Cryoport Systems (formerly Cell&Co) uses 8 technology products and services including Visual Website Optimizer, ISO 45001, GitLab CI, and more. Explore Cryoport Systems (formerly Cell&Co)'s tech stack below.

  • Visual Website Optimizer
    Analytics
  • ISO 45001
    Certificates
  • GitLab CI
    Continuous Integration
  • Zoho
    Customer Relationship Management
  • Font Awesome
    Font Scripts
  • GitLab
    Issue Trackers
  • jQuery Migrate
    Javascript Libraries
  • Cdata
    Tag Management

Media & News

Cryoport Systems (formerly Cell&Co)'s Email Address Formats

Cryoport Systems (formerly Cell&Co) uses at least 2 format(s):
Cryoport Systems (formerly Cell&Co) Email FormatsExamplePercentage
FLast@cell-and-co.comJDoe@cell-and-co.com
96%
FirLast@cell-and-co.comJohDoe@cell-and-co.com
4%
FLast@cryoport.comJDoe@cryoport.com
93%
First.Last@cryoport.comJohn.Doe@cryoport.com
4%
LastFirst@cryoport.comDoeJohn@cryoport.com
2%
First_Last@cryoport.comJohn_Doe@cryoport.com
1%

Frequently Asked Questions

Where is Cryoport Systems (formerly Cell&Co)'s headquarters located?

Minus sign iconPlus sign icon
Cryoport Systems (formerly Cell&Co)'s main headquarters is located at ZA Les Gravanches, 8, bis Rue Jacqueline Auriol, Clermont-Ferrand, Auvergne-Rhône-Alpes 63100, FR. The company has employees across 2 continents, including EuropeNorth America.

What is Cryoport Systems (formerly Cell&Co)'s official website and social media links?

Minus sign iconPlus sign icon
Cryoport Systems (formerly Cell&Co)'s official website is cryoport.com and has social profiles on LinkedIn.

How much revenue does Cryoport Systems (formerly Cell&Co) generate?

Minus sign iconPlus sign icon
As of October 2025, Cryoport Systems (formerly Cell&Co)'s annual revenue is estimated to be $3.8M.

What is Cryoport Systems (formerly Cell&Co)'s NAICS code?

Minus sign iconPlus sign icon
Cryoport Systems (formerly Cell&Co)'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Cryoport Systems (formerly Cell&Co) have currently?

Minus sign iconPlus sign icon
As of October 2025, Cryoport Systems (formerly Cell&Co) has approximately 201 employees across 2 continents, including EuropeNorth America. Key team members include Data Manager: M. D.Project Manager: K. Z.Directeur Des Systèmes D'information: C. L. G.. Explore Cryoport Systems (formerly Cell&Co)'s employee directory with LeadIQ.

What industry does Cryoport Systems (formerly Cell&Co) belong to?

Minus sign iconPlus sign icon
Cryoport Systems (formerly Cell&Co) operates in the Pharmaceutical Manufacturing industry.

What technology does Cryoport Systems (formerly Cell&Co) use?

Minus sign iconPlus sign icon
Cryoport Systems (formerly Cell&Co)'s tech stack includes Visual Website OptimizerISO 45001GitLab CIZohoFont AwesomeGitLabjQuery MigrateCdata.

What is Cryoport Systems (formerly Cell&Co)'s email format?

Minus sign iconPlus sign icon
Cryoport Systems (formerly Cell&Co)'s email format typically follows the pattern of FLast@cell-and-co.com. Find more Cryoport Systems (formerly Cell&Co) email formats with LeadIQ.

How much funding has Cryoport Systems (formerly Cell&Co) raised to date?

Minus sign iconPlus sign icon
As of October 2025, Cryoport Systems (formerly Cell&Co) has raised $25M in funding. The last funding round occurred on Dec 17, 2018 for $25M.

When was Cryoport Systems (formerly Cell&Co) founded?

Minus sign iconPlus sign icon
Cryoport Systems (formerly Cell&Co) was founded in 2012.

Cryoport Systems (formerly Cell&Co)

Pharmaceutical ManufacturingFrance201-500 Employees

Cryoport Systems is a comprehensive supply chain partner for the life sciences industry focused on meeting the challenges of the global cell and gene therapy market. We excel in the specialized management of the biopharmaceutical supply chain through our comprehensive offerings in logistics, BioServices and biostorage, cryopreservation, and consulting. Our expansive offerings are fully integrated to create a comprehensive platform that helps deliver risk mitigation, transparency, and certainty. With our expansive platform and decades of temperature-controlled supply chain expertise, Cryoport Systems helps Enable the Outcome for organizations from initial research through global commercialization.

Our facility in Clermont-Ferrand is designed to solve industry challenges by helping to drive efficiency and scale for clients so they can devote more of their efforts toward the discovery and development of personalized therapies to treat patients around the world.
•	Clinical sample management and central laboratory services
•	Patient sample processing, testing, and centralized management
•	Custom kit production for sample collection
•	Biostorage for secure management and storage of patient samples
•	Laboratory dedicated to pre-analytical activities, including sample preparation, such as PBMC isolation, aliquoting, and extractions (plasma, serum, etc)

Our Pont-du-Chateau location (formerly Cell & Co) has recently expanded to support additional clinical and commercial packaging, labelling, and kitting services at scale.
•	GMP Biorepository for clinical and commercial products
•	Regulatory & Qualified Person (QP) services including importation and QP release
•	Drug packaging, labelling, and distribution for clinical and commercial pharmaceutical products

✉ cnc-contact@cryoport.com

Section iconCompany Overview

Headquarters
ZA Les Gravanches, 8, bis Rue Jacqueline Auriol, Clermont-Ferrand, Auvergne-Rhône-Alpes 63100, FR
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2012
Employees
201-500

Section iconFunding & Financials

  • $25M

    Cryoport Systems (formerly Cell&Co) has raised a total of $25M of funding over 1 rounds. Their latest funding round was raised on Dec 17, 2018 in the amount of $25Mas a investment.

  • $1M

    Cryoport Systems (formerly Cell&Co)'s revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $25M

    Cryoport Systems (formerly Cell&Co) has raised a total of $25M of funding over 1 rounds. Their latest funding round was raised on Dec 17, 2018 in the amount of $25Mas a investment.

  • $1M

    Cryoport Systems (formerly Cell&Co)'s revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.